期刊文献+

玻璃体切割术联合组织型纤溶酶原激活物和速避凝治疗兔细菌性眼内炎所致纤维蛋白渗出 被引量:2

Vitrectomy combined with tissue plasminogen activator and fraxiparine for fibrin exudation caused by bacterial endophthalmitis in rabbits
原文传递
导出
摘要 目的探讨玻璃体切割联合组织型纤溶酶原激活物(r-tPA)和速避凝治疗细菌性眼内炎的效果。方法将40只青紫兰家兔随机分为实验组和对照组,每组各20只。向兔左眼玻璃体腔内注射105个/ml表皮葡萄球菌0.1ml,经过8~14h后,所有动物均接受玻璃体切割手术。手术中在实验组使用的平衡盐灌注液内加入速避凝,其终浓度为6IU/ml;手术后运用裂隙灯和间接检眼镜观察眼内纤维蛋白渗出的程度。若实验组手术后1、3、7、14、21d眼内存在纤维渗出,从手术后第1天开始向玻璃体腔内注射125mg/ml的r-tPA0.1ml。结果手术后实验组兔眼瞳孔区及玻璃体腔内纤维渗出较对照组显著减轻。结论玻璃体切割术联合r-tPA和速避凝的应用,能减轻兔细菌性眼内炎的纤维化程度,改善预后。 Objective To observe the therapeutic effects of vitrectomy combined with tissue plasminogen activator(r-tPA) and fraxiparine on bacterial endophthalmitis. Methods Forty pigmented rabbits were randomly divided into experimental and control group with 20 rabbits in each. The left eyes underwent intra vitreous injection with 10^5/ml bacteria of staphylococcus epidermidis 0.1 ml. After 8-14 hours, vitrectomy was performed on all of the animals. Fraxiparine with the final concentration of 6 IU/ml was only added to balanced salt solution in the experimental group during the operation, and the extend of intraocular fibrin exudation was observed by slit lamp and indirect ophthalmoscope after the operation. If the exudation occurred on the 1st, 3rd, 7th, 14th and 21st day postoperatively, 125 mg/ml r tPA 0.1 ml should be injected into vitreous from the 1st day after operation on. Results Fibrin exudation in the pupil area and vitreous body was much less in experimental group than that in the control group after the surgery. Conclusion vitrectomy combined with r-tPA and fraxiparine may alleviate the extent of fibrosis in bacterial endophthalmitis and improve the prognosis.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2005年第6期391-393,共3页 Chinese Journal of Ocular Fundus Diseases
关键词 内眼炎 玻璃体切除术 纤溶酶原激活剂 肝素 低分子量 Endophthalmitis Vitrectomy Plasminogen activators Heparin,low-molecular-weight
  • 相关文献

参考文献5

  • 1Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study. Arch Ophthalmol, 1995,113:1479-1496.
  • 2Ryan EH, Mizener JB. Tissue plasminogen activator and staphylococcus epidermidis endophthalmitis. Arch Ophthalmol, 1993,111:1117-1122.
  • 3Meredith TA, Trabelsi A, Miller MJ, et al. Spontaneous sterilization in experimental staphylococcus epidermidis endophthalmitis. Invest Ophthalmol Vis Sci, 1990,31:181-186.
  • 4武志峰,王光璐,张娟,张风,李雪菲,杨庆松.低分子量肝素——速避凝预防玻璃体切除术后眼内纤维蛋白渗出[J].中华眼底病杂志,1998,14(1):35-37. 被引量:8
  • 5Iverson DA, Katsura H, Hartzer MK, et al. Inhibition of intraocular fibrin formation following infusion of low molecular weight heparin during vitrectomy. Arch Ophthalmol, 1991,109:405-409.

二级参考文献6

  • 1Barraowcliffe TW,Annotation:Low molecular weight heparin(s).Br J Haematol,1995,90:1-9.
  • 2Iverson DA,Katsura H,Hartzer MK,et al.Inhibition on intraocular fibrin formation following infusion of low-molecular weight heparin during vitrectomy.Arch Ophthalmol,1991,109:405-409.
  • 3Jaffe GJ,Schwartz D,Han DP,et al.Risk factors for postvitrectomy fibrin formation.Am J Ophthalmol,1990,109:661-667.
  • 4Jaffe GJ,Abrams GW,Williams GA,et al.Tissue plasminogen activator for postvitrectomy fibrin formation.Ophthalmology,1990,97:184-189.
  • 5Johnson RN,Blankenship G,A Prospective,randomized,clinical trial of heparin therapy for postoperative intraocular fibrin.Ophthalmology,1988,95:312-317.
  • 6Chapman C,Iverson D,Hartzer M,et al.The effect of low molecular weight heparin on proliferative vitreoretinopathy induced in the rabbit eye.Invest Ophthalmol Vis Sci,1992,33(Suppl):818.

共引文献7

同被引文献23

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部